April 08, 2025
A Maryland federal judge has denied a British healthcare company's bid to dismiss a lawsuit alleging it stole trade secrets relating to a novel method of treating depression with psilocybin, the active ingredient in psychoactive mushrooms.
March 22, 2024
A London-based biochemical company cannot be allowed to escape across the pond with trade secrets related to using psilocybin as a mental health treatment, the University of Maryland, Baltimore, told a federal court, saying the company's minimum contacts with the state was its "months-long fraudulent scheme" to swipe intellectual property.
June 28, 2023
A U.K. company investigating potential psilocybin therapies has urged a Maryland federal judge to toss a suit accusing it of swiping trade secrets, saying the court lacks jurisdiction and the plaintiffs have failed to state a clear trade secret claim.
August 08, 2022
A company called Terran Biosciences Inc. has launched a suit in federal court claiming that a British company swiped trade secrets from a professor at the University of Maryland, Baltimore, related to a way to treat depression using psilocybin without its hallucinogenic effects.